Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis...

por Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Publicado 2014

Effects of personality on the association between paroxetine plasma concentration and response

por Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K
Publicado 2018

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan

por Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, Nakaji S, Nakamura K
Publicado 2014

Reduced plasma orexin-A levels in patients with bipolar disorder

por Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H
Publicado 2019

The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.

por Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, Norio Sugawara, Sunao Kaneko
Publicado 2014

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

por Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K
Publicado 2014

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.

por Moeko Noguchi-Shinohara, Masato Koike, Hirofumi Morise, Kiwamu Kudo, Shoko Tsuchimine, Junji Komatsu, Chiemi Abe, Sachiko Kitagawa, Yoshihisa Ikeda, Masahito Yamada
Publicado 2021

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer’s disease

por Moeko Noguchi-Shinohara, Masato Koike, Hirofumi Morise, Kiwamu Kudo, Shoko Tsuchimine, Junji Komatsu, Chiemi Abe, Sachiko Kitagawa, Yoshihisa Ikeda, Masahito Yamada
Publicado 2021

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

por Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K
Publicado 2013